Twist Bioscience Corporation
NASDAQ:TWST · NASDAQ Global Select
+$2.15 today
Vol 3.93M · Avg 1.53M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $122.7M |
| Short-term Investments | $49.0M |
| Receivables | $64.2M |
| Inventory | $33.5M |
| Other Current | $54.1M |
| Total Current Assets | $323.4M |
| PP&E (Net) | $181.9M |
| Goodwill | $82.2M |
| Intangible Assets | $13.0M |
| Long-term Investments | $68.1M |
| Other Non-current | $7.6M |
| Total Non-current Assets | $352.8M |
| Total Assets | $676.2M |
Analysis
Selected assets total $676.2M for Latest. The largest visible component is PP&E (Net) at $181.9M, about 26.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $183.0M -19.1% | $226.3M -21.0% | $286.5M -24.4% | $378.7M -18.7% | $465.8M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $49.4M -1.4% | $50.1M +0.3% | $49.9M -60.5% | $126.3M +949.4% | $12.0M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $57.3M +64.2% | $34.9M -20.8% | $44.1M +9.4% | $40.3M +41.1% | $28.5M | $533.8M | $399.4M | -$1.7B |
| Inventory | $28.3M +17.6% | $24.1M -24.9% | $32.1M -18.4% | $39.3M +23.6% | $31.8M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $14.9M +30.8% | $11.4M -2.7% | $11.7M | $0 | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $333.0M -4.0% | $346.8M -18.3% | $424.3M -28.9% | $596.5M +9.1% | $546.5M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $151.7M -6.0% | $161.3M -20.7% | $203.4M -5.1% | $214.4M +102.8% | $105.7M | $1.2B | $1.5B | $687.8M |
| Goodwill | $82.2M -4.2% | $85.8M +0.0% | $85.8M +0.0% | $85.8M +282.5% | $22.4M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $13.4M -7.3% | $14.5M -73.4% | $54.5M -8.8% | $59.7M +227.1% | $18.3M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $54.3M +3463.1% | $1.5M -45.7% | $2.8M | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $7.3M +66.0% | $4.4M -22.8% | $5.7M +14.6% | $5.0M -46.1% | $9.2M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $308.9M +15.5% | $267.5M -24.0% | $352.1M -3.5% | $364.9M +134.5% | $155.6M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $641.9M +4.5% | $614.3M -20.9% | $776.4M -19.2% | $961.4M +36.9% | $702.1M | $13.3B | $11.9B | $10.6B |
| Account Payables | $11.1M +580.6% | $1.6M -88.4% | $14.1M -30.1% | $20.1M +34.8% | $14.9M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $13.8M | $0 | $0 | $0 -100.0% | $1.6M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $2.7M -37.7% | $4.4M +19.5% | $3.7M +50.0% | $2.4M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $6.9M +223.0% | $2.1M -28.9% | $3.0M -13.7% | $3.5M +219.5% | $1.1M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $23.8M -31.3% | $34.6M +31.9% | $26.2M -33.8% | $39.6M +39.4% | $28.4M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $91.4M +28.7% | $71.0M -3.2% | $73.3M -19.1% | $90.7M +43.8% | $63.1M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $61.8M | $0 | $0 | $0 | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | -$46.0M -11402.9% | $407.0K -14.3% | $475.0K +691.7% | $60.0K -98.8% | $5.1M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $77.5M +9.7% | $70.6M -11.3% | $79.6M -2.1% | $81.3M +39.7% | $58.2M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $168.9M +19.3% | $141.6M -7.4% | $153.0M -11.1% | $172.0M +41.8% | $121.3M | $14.7B | $3.7B | $9.6B |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$1.3B -6.3% | -$1.2B -20.2% | -$1.0B -24.7% | -$828.4M -35.7% | -$610.6M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$627.0K -20.1% | -$522.0K +31.0% | -$756.0K +59.0% | -$1.8M -437.5% | $546.0K | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $473.0M +0.1% | $472.7M -24.2% | $623.4M -21.0% | $789.4M +35.9% | $580.8M | $9.1B | $7.7B | $3.3B |
| Total Debt | $137.3M +61.5% | $85.0M -9.6% | $94.1M -0.9% | $94.9M +50.8% | $62.9M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$45.7M +67.6% | -$141.3M +26.6% | -$192.4M +32.2% | -$283.8M +29.6% | -$402.9M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
$3.89B
uniQure N.V.
NASDAQ:QURE
$2.93B
Guardian Pharmacy Services, Inc.
NYSE:GRDN
$2.75B
Structure Therapeutics Inc.
NASDAQ:GPCR
$2.65B
Clover Health Investments, Corp.
NASDAQ:CLOV
$2.54B
Mesoblast Limited
NASDAQ:MESO
$1.85B
Viridian Therapeutics, Inc.
NASDAQ:VRDN
$1.53B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.21B
QuidelOrtho Corporation
NASDAQ:QDEL
$911.73M
BGM Group Ltd.
NASDAQ:BGM
$72.10M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does TWST have?
Twist Bioscience Corporation (TWST) reported $183.05M in cash and equivalents in fiscal 2025.
How much debt does TWST carry?
Twist Bioscience Corporation (TWST) reported $137.32M of total debt, with net debt of -$45,727,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.